• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Others

    AltruBio secures $225m for immune checkpoint programme development

    PHARMACEUTICAL TECHNOLOGY

    AltruBio to Participate in Upcoming May 2024 Medical Conferences

    GLOBENEWSWIRE

    AltruBio to Present at the Federation of (FOCIS) 2023 Annual Meeting

    GLOBENEWSWIRE

    AltruBio to Present at the 2023 BIO International Convention

    GLOBENEWSWIRE

    AltruBio Announces Poster Presentation at Digestive Disease Week Conference 2023

    GLOBENEWSWIRE

    AltruBio Announces Panels & Presentations at Three March Healthcare Conferences

    GLOBENEWSWIRE

    AltruBio Announces Poster Presentation on Immune Checkpoint Enhancer, ALTB-168

    GLOBENEWSWIRE

    AltruBio Presents Data from Phase 1b Study Evaluating ALTB-168 in Patients

    GLOBENEWSWIRE

    AltruBio Hosting R&D Update on Immune Checkpoint Enhancer Platform

    GLOBENEWSWIRE

    AltruBio Announces FDA Clearance of IND Application for ALTB-268

    GLOBENEWSWIRE

    AltruBio to Present New Phase 1b Data Evaluating Neihulizumab (ALTB-168)

    GLOBENEWSWIRE

    AltruBio President and CEO Judy Chou Appointed to the Gov Board of California

    GLOBENEWSWIRE

    AltruBio President and CEO Judy Chou to Participate at the Longwood

    GLOBENEWSWIRE

    AltruBio to Present at the 2022 BIO International Convention

    GLOBENEWSWIRE

    AltruBio Completes Enrollment in PI Study of Neihulizumab in SR-aGVHD

    GLOBENEWSWIRE

    AltruBio to Present at BIO CEO & Investor Conference

    GLOBENEWSWIRE

    AltruBio to Present Abstract on Checkpoint Regulator Neihulizumab Novel Therapy

    GLOBENEWSWIRE

    AltruBio snags new CMO with pivot to immunology—Chutes & Ladders

    FIERCEBIOTECH

    AltruBio Appoints Jesse Hall

    GLOBENEWSWIRE

    After a major facelift, AltruBio says it`s ready for a pivotal fight against

    ENDPTS

    All-new AltruBio relaunches with $63M Series A

    FIERCEBIOTECH

    AltruBio’s Neihulizumab Granted Fast Track Designation by the FDA

    GLOBENEWSWIRE

    AltruBio Announces First Patient Dosed in Phase 1b Study of Neihulizumab

    PRESS RELEASE

    AltruBio moves forward with clinical development of Neihulizumab in Steroid

    PIPELINEREVIEW

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.